SurgoCap Partners Portfolio holdings
SurgoCap Partners is an investment firm focused on how technology innovation reshapes global markets over the long term. Mala Gaonkar, a former portfolio manager at Lone Pine Capital, founded it in 2022 and leads its investing as managing principal and chief investment officer. The firm runs private funds, in the US and overseas, for sophisticated and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$265M |
| 2 |
McKesson
MCK
|
+$173M |
| 3 |
Hilton
HLT
|
+$167M |
| 4 |
Mercado Libre
MELI
|
+$125M |
| 5 |
TSMC
TSM
|
+$75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$341M |
| 2 |
Corning
GLW
|
+$204M |
| 3 |
Argan
AGX
|
+$120M |
| 4 |
Intuitive Surgical
ISRG
|
+$102M |
| 5 |
Medline
MDLN
|
+$33.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.23% |
| 2 | Healthcare | 23.71% |
| 3 | Financials | 22.29% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 9.27% |
Similar funds
SurgoCap Partners's Q3 2026 Portfolio in Review
As of Q3 2026, SurgoCap Partners held 16 positions worth $3.04B, down 1.7% from $3.09B the previous quarter. Its ten largest holdings account for 96% of the portfolio.
SurgoCap Partners deployed $121M of net new capital in Q3 2026, opening 3 new positions and adding to 7 existing holdings. Its largest new stake was Microsoft: 573,423 shares worth $294M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Medline, an estimated $33.3M trimmed.
- SurgoCap Partners's largest Q3 2026 buy was Microsoft: 573,423 shares worth $294M.
- SurgoCap Partners added most to McKesson in Q3 2026, an estimated $173M increase.
- SurgoCap Partners's biggest Q3 2026 reduction was Medline, cutting an estimated $33.3M.
- SurgoCap Partners fully exited Alphabet (Google) Class C in Q3 2026, selling an estimated $341M.
- SurgoCap Partners's ten largest holdings make up 96% of its $3.04B portfolio in Q3 2026.
- SurgoCap Partners opened 3 new positions and closed 5 in Q3 2026.
- SurgoCap Partners's portfolio value fell 1.7% quarter-over-quarter to $3.04B.
Based on SurgoCap Partners's 13F filing for Q3 2026, filed 16 Nov 2026.